NUCLEIQ Trademark

Trademark Overview

On Tuesday, May 13, 2025, a trademark application was filed for NUCLEIQ with the United States Patent and Trademark Office. The USPTO has given the NUCLEIQ trademark a serial number of 99182331. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 13, 2025. This trademark is owned by Creyon Bio, Inc. The NUCLEIQ trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development services of new pharmaceutical products
nucleiq

General Information

Serial Number99182331
Word MarkNUCLEIQ
Filing DateTuesday, May 13, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, May 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch and development services of new pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 13, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCreyon Bio, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCarlsbad, CA 92010

Trademark Events

Event DateEvent Description
Tuesday, May 13, 2025NEW APPLICATION ENTERED
Tuesday, May 13, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

nucleiq products pharmaceutical services development research